Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia

Leukemia

Volumn 8, Issue 12, 1994, Pages 2047-2051

  Robertson, L E ^a,b   Estey, Elihu ^a   Kantarjian, Hagop ^a   Koller, Charles ^a   O'Brien, Susan ^a   Brown, Barry ^a   Keating, Michael J ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AMSACRINE; ANDROGEN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUDARABINE; FLUDARABINE PHOSPHATE; HYDROXYUREA; MITHRAMYCIN; PREDNISONE; VINCRISTINE; ZORUBICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER RISK; CANCER STATISTICS; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0028670763     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992;84:1422-1427.
2. Davis JW, Weiss NS, Armstrong BK. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1987; 78:91-94.
3. Malica S, Alberti A. Second neoplasms in chronic lymphocytic leukaemia: analysis of incidence as a function of the length of follow-up. Haematologica 1989;74:481-485.
4. Manusow D, Weinerman DH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975;232:267-269.
5. Bracey AW, Maddox AM, Immken L, Hus SM, Marks ME. Coexistence of myelodysplastic syndrome and untreated chronic lymphocytic leukemia with development of acute myeloid leukemia immediately after treatment of chronic lymphocytic leukemia. Am J Hematol 1989;30:174-180.
6. Wallis JP, Joyner MV. Acute myeloid leukaemia developing in a patient with longstanding treated chronic lymphocytic leukemia. Haematol 1986;75:229-231.
7. Manoharan A, Catovsky D, Clein P, Traub NE, Costello C, O'Brien M, Boralessa H, Galton DAG. Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases. Br J Haematol 1981;48:111-116.
8. Zarrabi MH, Gruwald HW, Rosner F. Chronic lymphocytic leukemia terminating in acute leukemia. Arch Intern Med 1977; 137:1059-1064.
9. Roberts PD, Forster PM. Chronic lymphocytic leukaemia associated with acute myelomonocytic leukaemia. Br J Haematol 1973;23:203-206.
10. Catovsky D, Galton DAG. Myelomonocytic leukemia supervening or chronic lymphocytic leukemia. Lancet 1970;1:478-479.
11. Robertson LE, Pugh W, O'Brien S, Kantarjian H, Hirsh-Ginsberg C, Cork A, McLaughlin P, Cabanillas P, Keating MJ. Richter's Syndrome: a report on 39 patients. J Clin Oncol 1993;11:1985-1989.
12. Berk PD, Goldberg JD, Silverstein MN, Weinfeld A, Donovan PB, Ellis JT, Landaw SA, Laszlo J, Najean Y, Pisciotta AV, Wasserman LR. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med 1981; 304:441-447.
13. Greene MH, Boice JD, Greer BE, Blessing JA, Dembo AJ. Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer. N Engl J Med 1982;307:14-21.
14. Bergsagel DE, Phil D, Bailey AJ, Langley R, MacDonald RN, White DF, Miller AB. The chemotherapy of plasma-cell myeloma and the incidence of acute leukemia. N Engl J Med 1979; 301:743-748.
15. Kempin S. Late hematologic complications after treatment of Hodgkin's disease. In: Lacher MJ, Redman JR, eds. Hodgkin's disease: the consequences of survival. Philadelphia: Lea and Febiger, 1990:63-111.
16. Travis LB, Curtis RE, Glimelius B, Holoway E, Van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M, Wacholder S, Inskip P, Tucker MA, Fraumeni JF Jr, Boice JD Jr. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993;85:1932-1937.
17. Kantarjian HM, Keating MJ, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic and prognostic features. J Clin Oncol 1986;4:1748-1757.
18. Peetre C, Gullberg U, Nilsson E, Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. J Clin Invest 1985;78:1694-1700.
19. Ulich TR, del Castillo J, Yin S. Tumor necrosis factor exerts dose-dependent effects on erythropoiesis and myelopoiesis in vivo. Exp Hematol 1990;18:311-315.
20. Lindermann A, Ludwig WD, Oster W, Mertelsman R, Hermann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood 1988;73:880-884.
21. Foa R, Massaia M, Cardona S, Tos AG, Bianchi A, Attisano C, Guarini A, di Celle PF, Fierro MT. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells. A possible regulatory role of TNF in the progression of the disease. Blood 1990;76:393-400.
22. Hoffbrand AV, Panayiotidis P, Reittie J, Ganeshaguru K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 1993;30:306-317.